www.archive-org-2013.com » ORG » N » NAABT

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".

    Archived pages: 170 . Archive date: 2013-10.

  • Title: Buprenorphine Treatment- Find doctors - opioid addiction resources from NAABT
    Descriptive info: .. Search naabt.. org.. The National Alliance of Advocates.. for Buprenorphine Treatment.. Buprenorphine (Suboxone.. , Subutex.. 3.. , Zubsolv.. 4.. , Probuphine.. 5.. ) is an opioid medication used to treat opioid addiction in the privacy of a physician's office.. 1.. Buprenorphine can be dispensed for take-home use, by prescription.. This, in addition to the pharmacological and safety profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.. 2.. About Us.. Find.. Buprenorphine Treatment.. Buprenorphine Education.. Online.. Support.. Communities.. Info for.. Treatment.. Providers.. Patients:.. Find a Buprenorphine Physician.. Patient/Physician Matching System.. Have a certified buprenorphine.. prescribing physician contact you:.. Get Started.. Physicians:.. Help Patients Now.. Find patients searching for.. buprenorphine treatment near you:.. Find Physicians, Counselors Therapists, Pharmacies, Treatment Facilities and other local resources.. Enter Zip Code:.. Download useful info.. Select.. In the News.. FDA rejects Probuphine - see NAABT Blog - 9/17/13.. FDA approves Zubsolv - in pharmacies now.. Buccal Bup/Nx Film filed with FDA - 7/31/2013.. September is Recovery Month.. Receive Our Newsletter.. Read More.. Mike's Story.. Watch Now.. The Purpose of Buprenorphine Treatment:.. To suppress the debilitating symptoms of cravings and withdrawal, enabling the patient to engage in therapy, counseling and  ...   15 ways to save money on treatment.. Free Printed Resources.. Buprenorphine Side Effects.. Patient Stories.. Multimedia Files.. Info for Treatment Providers.. How to Dispose of Unused Meds - FDA.. naabt.. org.. Home.. About.. Contact.. Glossary.. 6 ways to find buprenorphine treatment.. Privacy Policy.. Terms.. Understand Buprenorphine Treatment.. Donate.. NAABT.. org - Blog.. Sitemap.. The National Alliance of Advocates for Buprenorphine Treatment.. is a.. non-profit.. organization charged with the mission to:.. Educate the public about the disease of opioid addiction and the buprenorphine treatment option.. Help reduce the stigma and discrimination associated with patients with addiction disorders.. Serve as a conduit connecting patients in need of treatment to buprenorphine treatment providers.. U.. S.. Food and Drug Administration,.. FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone.. approved to treat opiate dependence.. Center for Substance Abuse Treatment.. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction.. Treatment Improvement Protocol (TIP) Series 40.. DHHS Publication No.. (SMA) 04-3939.. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.. Subutex Discontinued.. in the US market in late 2011.. FDA approved 7/3/2013.. see buprenorphine pipeline graphic.. Rejected by FDA 4/30/2013 - Future Unknown -.. Probuphine denied by FDA..

    Original link path: /
    Open archive

  • Title: Buprenorphine treatment and opioid addiction resources from The National Alliance of Advocates for Buprenorphine Treatment
    Descriptive info: Education.. Online.. Treatment.. The National Alliance of Advocates for Buprenorphine Treatment is a non-profit organization charged with the mission to:.. Serve as a conduit connecting patients in need of treatment to qualified treatment providers.. We incorporated as a non-profit corporation in Connecticut April 1, 2005.. We have.. 501(c)3 tax exempt status with the IRS as a charitable organization.. Any donations are tax deductible for the year in which the donation was made.. We are physically located at 411 Colt Highway, Farmington, CT.. Voluntary Discloser:.. Funding for this organization is provided by anonymous donors whose lives were touched by evidence-based addiction treatment and were willing to contribute to the cause.. In past years NAABT, Inc.. has also asked for and received funding from pharmaceutical companies in the form of Unrestricted Educational  ...   NAABT s activities.. is solely responsible for all of its activities.. We provide a source for educational information, plus a tool for helping patients connect with physicians.. We will strive to remain a non biased, reputable, and accurate source for those seeking information on evidence-based addiction treatments.. Buprenorphine is not a cure nor a miracle medication, but a new and effective tool in fighting opioid addiction.. Medication is only a small part of a comprehensive recovery plan.. We at NAABT wish you and your loved ones the very best in treatment and in life.. Let us know if we can help you further.. Mailing Address:.. P.. O.. Box 333.. Farmington, CT 06034.. Fax: 860.. 269.. 4391.. Click here to send us an email.. This page was last modified on : 02/11/2013..

    Original link path: /about_us.cfm
    Open archive

  • Title: Buprenorphine Treatment Facts - Help for Opioid Addiction
    Descriptive info: The Education Sections are geared toward education on addiction disorders and the Buprenorphine Treatment Option, which will help you to make the right decision in opioid addiction treatment.. Adobe Acrobat Viewer is required to view Adobe Acrobat (PDF) files.. If you don't have Acrobat Viewer already installed,.. click here to download it now.. Have a certified prescribing physician contact you.. The Patient/Physician Matching System.. I'm a Patient.. I'm a Physician.. Find other local resources (physicians,.. counselors, pharmacies, studies,.. meetings, etc.. ).. Enter Zip Code:.. Frequently Asked Questions.. The most common questions regarding buprenorphine treatment and evidence-based addiction treatment.. Educational Essays.. Information  ...   limiting the number of patients buprenorphine- prescribing physicians can treat at any one time.. Stories from Buprenorphine Treatment patients.. Audio/Video Files Watch and listen to audio files and videos from naabt.. Literature.. PDF files of naabt.. org literature, the TIP 40, NIDA studies, science-related publications and much more.. What is Buprenorphine Treatment Like?.. An in-depth look at buprenorphine treatment from preparation for induction to alternative treatments to remain addiction free.. Links.. Relevant websites, downloads, images of interest.. History of opioid-related laws in the United States from the 1800s to today.. Comprehensive glossary of terms used in Buprenorphine Treatment, addiction, psychology and more..

    Original link path: /education.cfm
    Open archive

  • Title: National Alliance of Advocates for Burprenorphine Treatment - Membership Information
    Descriptive info: Info for Treatment Providers:.. Information regarding buprenorphine treatment, addiction and other related topics for Physicians, Therapists/Counselors and Pharmacists.. Up-to-date Patient/Physician.. Matching System Statistics.. Since the national launch of the Patient Physician Matching System on September 1, 2006, to 10/01/2013 there have been.. 56960.. patients contacted by at least one of the.. 3761.. participating physicians.. There are currently.. 199.. patients in the system that are currently seeking a physician.. Learn about the Patient/Physician Matching System PPMS.. Maps.. (.. Patients.. |.. Physicians.. ) |.. Provider Registration.. Counselors Therapists.. Pharmacists.. Nurses.. org – Patient/Physician.. Matching System.. Substance Abuse.. and Mental.. Health Services.. Administration.. Physician.. Certification.. Physician and.. Pharmacist.. Frequently Asked.. Questions.. Most Popular.. Physician Downloads.. Online Support.. Community Forum.. org Patient/Physician Matching System.. What is TreatmentMatch.. org?.. org physician registration instructions.. Physician Registration Page.. How to use TreatmentMatch.. Back to top.. SAMHSA Physician Locator (add, delete, edit).. Physicians already listed on the locator but want to make a change, add a practice location or delete their listing, can now do that themselves online.. Click this link for instructions:.. http://buprenorphine.. samhsa.. gov/pls/bwns/updtcntct2$.. startup.. If not already listed, DATA-2000 waived physicians may call 1-866-BUP-CSAT (1-866-287-2728) or e-mail.. info@buprenorphine.. gov.. with requests to be added to the Locator.. See current locator listing at:.. www.. naabt.. org/local.. The DEA must also be notified when a waived physician changes the primary practice address at which they intend to treat opioid addiction under the authority of their DATA 2000 waiver.. Call the DEA Office of Diversion Control at 1-800-882-9539.. Phone numbers for local DEA offices can be found on the DEA Web site at.. http://www.. dea.. Substance Abuse and Mental Health Services Administration (SAMHSA) website.. Back to top.. Physician Certification.. How to become certified to prescribe buprenorphine for opioid addiction.. Physician Buprenorphine Certification Events both live and online.. BupPractice.. com - American Society of Addiction Medicine (ASAM) online certification training.. American Academy of Addiction Psychiatry (AAAP) online certification training.. Most popular physician downloads.. Physician and Pharmacist Frequently Asked Questions.. Billing codes 8/2007.. NEW Blank intent form to treat up to.. 100 patients.. --fax to 240-276-1630.. TIP 40.. PDF (Clinical Guidelines for the Use of Buprenorphine).. More TIPs on.. literature.. page.. The.. 3 day rule.. (dispensing buprenorphine without a waiver).. DEA Articulates Policy on the Use of.. Buprenorphine for Pain.. - Letter to Dr.. Heit.. Other.. DEA regulations.. cleared up.. Suboxone Film Package insert, prescribing information.. (PI).. Preventing.. Precipitated Withdrawal.. / COWS.. How Buprenorphine Works--.. Receptor sheet.. Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for the Maintenance and detoxification Treatment of Opiate Addiction FORM.. updated 7/2012.. Please see our.. page for more downloads.. Therapists Counselors.. Evidence-Based.. Counselor/.. Therapist Locator.. NIDA/SAMHSA-ATTC.. Blending Initiative.. org Patient/Physician.. Matching System (PPMS).. Patient Online Support Community.. Physician and Pharmacist.. An Introduction to The.. Role of Medication in.. Substance Use.. Popular Downloads.. Substance Abuse and Mental.. Health Services Administration.. Evidence-Based Counselor/Therapist Locator.. Sign up: To be on the naabt.. ; to receive a free Resource Kit; to receive our free newsletter.. Counselor login and resources.. Buprenorphine resource locator.. (see your listing).. See map of currently registered counselors.. What is the Patient/Physician Matching System?.. Patient Registration.. Register your patients on the PPMS.. to help locate a certified  ...   principles of intensive outpatient treatment; services and treatment models; modifications for distinct population groups; culturally competent treatment; screening and patient placement criteria; counseling methods and techniques, including involvement of families; and the continuum of care.. The TIP also covers such important issues as how to improve early retention, provide the appropriate length and intensity of services, provide the most promising mix of wrap-around services for positive client outcomes, and arrange ongoing care in the community.. http://download.. ncadi.. gov/prevline/pdfs/TIP_47.. TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs.. Opioid addiction is a problem with high costs to individuals, families, and society.. This TIP provides a detailed description of medication-assisted treatment for opioid addiction, including optional approaches such as comprehensive maintenance treatment, detoxification, and medically supervised withdrawal.. gov/Prevline/pdfs/bkd524.. pdfCompanion Kap Keys.. http://kap.. gov/products/tools/keys/pdfs/KK_43.. TIP 44: Substance Abuse Treatment for Adults in the Criminal Justice System.. Research consistently demonstrates a strong connection between criminal activity and substance abuse; research also finds that involvement in substance abuse treatment reduces recidivism for offenders who use drugs.. This TIP presents clinical guidelines to assist counselors in dealing with problems that routinely arise because of their clients status in the criminal justice system.. gov/Prevline/pdfs/bkd526.. TIP 39: Substance Abuse Treatment Family Therapy.. This best-practice guideline for the treatment of substance use disorders focuses on how substance abuse affects the entire family and how substance abuse treatment providers can use principles from family therapy to change the interactions among family members.. gov/prevline/pdfs/bkd504.. TIP 42: Substance Abuse Treatment for Persons With Co-Occurring Disorders.. This TIP identifies key elements of programming for co-occurring disorders in substance abuse treatment agencies.. The elements described have relevance for mental health agencies and other service systems that seek to coordinate mental health and substance abuse services for their clients who need both.. gov/prevline/pdfs/bkd515.. TIP 37: Substance Abuse Treatment for Persons With HIV/AIDS.. This installment of the Treatment Improvement Protocol (TIP) Series discusses the unique substance abuse treatment needs of a person with HIV/AIDS.. Topics covered include a general overview of HIV/AIDS, medical treatment, mental health treatment, primary and secondary modes of HIV prevention, and many other pertinent issues.. ncbi.. nlm.. nih.. gov/books/bv.. fcgi?rid=hstat5.. chapter.. 64746.. TIP 35: Enhancing Motivation for Change in Substance Use Disorder Treatment.. This TIP shows how substance abuse treatment staff can influence change by developing a therapeutic relationship that respects and builds on the client s autonomy and, at the same time, makes the treatment clinician a partner in the change process.. gov/Prevline/pdfs/SMA06-4190.. The 3 day rule (dispensing buprenorphine without a waiver).. DEA Articulates Policy on the Use of Buprenorphine for Pain- Letter to Dr.. Other DEA regulations cleared up.. Suboxone/Subutex Package insert, prescribing information (PI).. Preventing Precipitated Withdrawal / COWS.. How Buprenorphine Works--Receptor sheet.. Buprenorphine-Stocking.. Pharmacy Locator.. Substance Abuse and.. Mental Health Services.. Physician and.. Buprenorphine-Stocking Pharmacy Locator.. ; to receive a free counter display; to receive our free newsletter.. View the Buprenorphine Resource Locator and your listing.. org Patient/Physician Matching System.. These patients may benefit from online patient peer support.. Patients can participate 24/7 in the online buprenorphine community at.. here.. Tap 30.. PPMS physician registration instructions.. Physician Registration.. How to utilize the PPMS.. This page was last modified on : 10/19/2012..

    Original link path: /providers.cfm
    Open archive

  • Title: Archive of NAABT Newsletters
    Descriptive info: Newsletter Archives.. Below is a collection of Buprenorphine Treatment-related newsletters published by the National Alliance of Advocates for Buprenorphine Treatment which contain the latest information about NAABT and its website, treatment studies, law changes and more.. 2013.. September.. 2011.. December.. June.. 2010.. 2009.. January / February.. 2008.. November / December.. August / September / October.. April / May.. 2007.. September - Special Edition.. July, August, September.. April, May, June.. March.. February.. January.. 2006.. October / November.. July / August.. May.. April.. 2005.. Newsletter Sign-Up.. To receive our newsletter, unsubscribe, or change your profile, enter your email address.. Email:..

    Original link path: /newsletter/newsletters.cfm
    Open archive

  • Title: National Alliance of Advocates for Buprenorphine Treatment
    Descriptive info: The National Alliance of Advocates.. >.. Sep.. 16.. FDA protects us from lifesaving drug.. No Comments.. FDA says no to safer, longer lasting, form of buprenorphine that cannot be lost, stolen, sold or accidentally ingested by children.. Imagine a form of buprenorphine which could not be lost stolen or sold, delivered a consistent daily dose (could not be overdosed or underdosed), ensured at least 6 months of medication compliance, had absolutely no risk of accidental pediatric exposure, and would still be effective at treating opioid addiction.. Sounds like a miracle, or at least a major step forward, right? Not according to the FDA who earlier this year rejected such an advancement in treatment and for reasons largely unrelated to the medication’s lifesaving potential.. Meanwhile, the CDC reports 45 people a day die from prescription opioid overdose.. Read more.. Dec.. 12.. Maine rations addiction treatment via Medicaid.. Buprenorphine News.. 8 Comments.. A cost-cutting task force is considering a two-year limit on Medicaid coverage for buprenorphine treatment for addiction.. which would force many current, stable patients to taper off this lifesaving medication within 30 days.. Maine’s proposal is especially disturbing when you consider these two very important news releases last month.. First, the.. CDC reports prescription drug overdose deaths are on the rise.. , with opioid painkiller overdoses accounting for 40 deaths a day nationwide.. Second, the largest study to date of.. Suboxone used for the treatment of prescription drug addiction produced positive results.. The study clearly shows that when this effective treatment is discontinued, and  ...   “.. 2011 National drug control strategy.. ” he was asked about elimination of the 30/100 patient limit plaguing buprenorphine providers, their patients and their loved ones.. This was the only question of the conference met with spontaneous applause.. Mr.. Kerlikowske was caught by surprise and admitted he was completely uninformed about a limit, and gave no indication that he even knew anything about the legislation pertaining to buprenorphine.. This is alarming in light of the new.. CDC report.. showing 40 people a day die from prescription opioid overdose, 15,000 a year (in 2008).. Meanwhile, patients are being denied lifesaving treatment due to effective rationing of care through government imposed patient caps.. A search of the ONDCP website shows ZERO results for a “Suboxone” or “Subutex” and only two mentions of “buprenorphine” which were only incidental mentions and not about buprenorphine.. Jun.. 15 ways to save money on buprenorphine treatment.. 2 Comments.. Manufacturer’s Copay card $50 toward out-of-pocket medication cost-.. Third party prescription discount cards –.. Buy your own drug test kits online -.. Marketing research opportunities –.. Insurance –.. Manufacturer’s free meds program –.. Partial prescription fills-.. Generics Available.. Clinical studies –.. Negotiate with the physician –.. Less frequent office visits -.. Lower dose –.. Referral fee –.. Methadone Clinics –.. Shop around-.. Categories.. (3).. Archives.. September 2013.. December 2011.. November 2011.. June 2011.. Favorite Links.. Buprenorphine Educational Materials.. Free Resource kit.. Addiction Survivors.. Treatment Match.. Alcohol Answers.. Tag Cloud.. buprenorphine news.. Feeds.. RSS Feeds.. Currently pending FDA approval.. Expected approval in July 2013..

    Original link path: /blog/
    Open archive

  • Title: Mike's Story - Buprenorphine Public Service Announcements and Short Web Stories
    Descriptive info: More to Watch:.. Webisode #1.. Webisode #2.. Additional Help:.. Physician List.. Resource Kit.. Webisode #3.. Before becoming addicted himself, Mike thought that addiction was a choice.. With an uncontrollable compulsion to take more and more pills, and an inability to 'just stop', he soon realized that addiction is a chronic medical condition.. He had to get better.. His intense research about the buprenorphine treatment option led him to naabt.. It was there he found the educational resources to make an informed decision if the treatment was right for him.. There Mike also found peer support to ask questions  ...   massive amounts of painkillers one day to putting myself in moderate to mild withdrawals and with less than 12mg of Suboxone, within two to three hours, I felt as if I had never taken a painkiller in my life.. Mike did not rely on the medication alone.. He found a therapist, both in-person and online peer support, and the loving support of his wife and family as the foundation for his recovery.. Mike is an addiction survivor and has not misused opioid painkillers since beginning treatment in 2006.. Visit our YouTube page for sharing options on MySpace, Facebook, etc..

    Original link path: /mike/
    Open archive

  • Title: Tax deductible donations to The National Alliance of Advocates for Buprenorphine Treatment
    Descriptive info: Frequently.. Asked.. Educational.. Essays.. What is Treatment Like?.. 30/100.. Patient.. Limit.. Patient.. Stories.. We welcome all donations.. We have 501c(3) tax exempt status with the IRS as a charitable organization.. Donations are tax deductible in the year which the donation was made.. Donation Options.. There are three options for making donations.. The first is a recurring donation/subscription which can be made in any amount on a weekly, monthly or yearly basis.. The second option is to make a one-time donation of  ...   Make a recurring donation:.. Donation amount:.. Select Amount.. $5.. 00.. $10.. $15.. $20.. $25.. $30.. $35.. $40.. $45.. $50.. $55.. $60.. $65.. $70.. $75.. $80.. $85.. $90.. $95.. $100.. Frequency of donation:.. Weekly.. Monthly.. Yearly.. One-time donation:.. Mail donation:.. NAABT,Inc.. Box 333.. Farmington, CT 06034.. Your contribution will be used for:.. The continuing education and dissemination of information concerning opioid addiction treatment.. Our mission to reduce the stigma and help connect patient to physician.. See about us for more details:.. org/about_us.. cfm..

    Original link path: /donate.cfm
    Open archive

  • Title: FAQ about Buprenorphine (Suboxone Subutex) Opioid Addiction and Treatment
    Descriptive info: Print.. | Font Size.. To learn more click on the topic which interests you.. If you have a question which is not included, please email us and we will try to answer it.. Is buprenorphine treatment just trading one addiction for another?.. No– with successful buprenorphine treatment, the compulsive behavior, the loss of control of drug use, the constant cravings, and all of the other hallmarks of addiction vanish.. What exactly is Buprenorphine?.. Buprenorphine (BYOO-pre-NOR-feen) (.. 'bū.. -pre-.. 'nôr.. -fēn) (C.. 29.. H.. 41.. NO.. ) is a semi-synthetic opioid derived from thebaine.. (found in the Poppy plant).. Common Buprenorphine side effects: Headache, Constipation, Dry mouth.. Water, MiraLAX®, Biotene®.. What drugs are opioids?.. Examples of brand name opioids are: OxyContin®, Percocet®, Palladone®(taken off the market 7/2005), Vicodin®, Percodan®, Tylox® and Demerol® among others.. What’s this agonist / antagonist stuff?.. Properties of some drugs; and essential in understanding why buprenorphine is unique.. How do opioids work in the brain?.. Opioids attach to receptors in the brain, which leads to a release of dopamine and causes feelings of euphoria.. Are there exceptions when Buprenorphine may be administered by a practitioner without the DATA 2000 waiver?.. Yes.. It may be dispensed by anon-wavered physician for up to 72 hours for the treatment of acute withdrawal while longer term treatment is being worked out.. How does Buprenorphine work in the brain?.. The Buprenorphine tends to occupy the receptors without all of the opioid effects.. Are there other uses for Buprenorphine?.. Buprenorphine (in injectable form)has been used to treat pain for many years.. What exactly are opioid receptors?.. These are protein molecules that exist on the surface of nerve cell membranes.. They provide a way for the body to experience the effects of opioids.. What is addiction?.. Addiction is uncontrollable compulsive behavior caused by alterations of parts of the brain from repeated exposure to highly euphoric responses.. What is withdrawal?.. Withdrawal syndrome consists of a predictable group of signs and symptoms resulting from abrupt removal of, or a rapid decrease in the regular dosage of, a psychoactive substance.. Is continued addictive behavior a voluntary behavior?.. The initial decision to take drugs is mostly voluntary.. However, when drug misuse takes over, a person's ability to exert self control can become seriously impaired.. What are examples  ...   prescribe it for opioid addiction treatment.. Is buprenorphine addictive?.. Although there is the potential for addiction to buprenorphine, the risk is low.. Few people develop the dangerous uncontrollable compulsion to buprenorphine that we know as addiction.. Can someone switch from methadone to buprenorphine?.. It recommended that the transition is made at 30mg or less of methadone.. Does insurance cover it?.. Most insurance companies cover it.. You might be able to file the claim yourself if your doctor won't accept your insurance.. What if I miss a dose?.. If you miss a dose and remember it.. Why are doctors limited to only helping 30/100 people at a time?.. The same law (DATA-2000) that allows physicians to prescribe certain opioid medications for opioid addiction from their office also limits how many patients they can treat.. What if I need pain medication for surgery, or acute pain?.. You will still be able to be treated for pain with elective dental or surgical procedures.. How soon can a work schedule be resumed?.. It is recommended to take the first day of treatment off.. What is the DATA 2000?.. A law that allows doctors to treat opioid addiction in-office.. What is the Naloxone for?.. Naloxone is present in Suboxone to discourage misuse, only.. It serves no other purpose.. Is Buprenorphine safe for people with a co-existing psychological illness?.. Many people use drugs because they are knowingly or unknowingly self-medicating for an underlying psychiatric condition.. What are the statistics with regard to opioid addiction and use in the US?.. Office of National Drug Control Policy (ONDCP), there were an estimated 810,000 to 1,000,000 individuals addicted to heroin in the US in the year 2000.. What is Precipitated withdrawal?.. A withdrawal syndrome initiated by another medication.. Naltrexone? What is it and what does it do?.. Naltrexone is a medication that blocks the effects of opioids.. It has shown evidence of reducing cravings.. Where can my doctor get help in using buprenorphine?.. pcssb.. Is my medical information confidential?.. The confidentiality of alcohol and drug dependence patient records is protected by federal law and regulations.. Does buprenorphine show up in an employer drug screening?.. It is becoming more common for an employer to test for buprenorphine.. Although, if testing for opiates in general buprenorphine will not be detected..

    Original link path: /faqs.cfm
    Open archive

  • Title: Buprenorphine Education: Introduction to Buprenorphine learn about treatment
    Descriptive info: Educational Essays Introduction.. To gain a thorough understanding of how Buprenorphine treatment can help people addicted to opioids, you must have an understanding of opioids, addiction, stereotypes, existing treatments, and some basic pharmacology.. The text contained in this section is a collection of articles meant to give an overview and to aid in understanding these issues so that you can completely understand the scope of today's opioid addiction problems.. Here you will learn the definitions of opioids and opiates, what opioid addiction is and what it is like, and the difference between physical dependence and addiction.. A brief history of opioids and addiction will help you understand why opium and substances derived from it became a "drug" while tobacco did not.. It covers the stereotypes of the drug addicted and explains the events that help shape our image of the addicted.. This website offers information on the most up to date, scientific approach to the treatment of Opioid addiction.. Suboxone (Buprenorphine/Naloxone) received approval by the FDA on October 8, 2002.. It is state-of-the-art medication to treat the medical condition of Opioid addiction.. It is improving the quality of life for patients in recovery and giving them hope, dignity, and the ability to have a normal life again.. There has been much damage done by the negative stereotype of addiction.. Even the medical profession has held a negative stereotype causing resistance to getting involved in helping people with this brain disease.. Until recently, the image of a weak morally depraved person has encouraged a punitive perspective and slowed science and research of this medical condition.. The following is a thorough explanation of physical dependence and addiction and how buprenorphine works to treat it.. Finally, there is a day-by-day and week-to-month description of what to expect when starting Buprenorphine treatment.. The key to solving the problem of addiction  ...   they become less sensitive and require more opioids to produce the same effect.. Through Technical Explanation of Buprenorphine.. Most of the information contained in this section is excerpts from the TIP 40 publication (treatment improvement protocol) issued by the U.. Department of HHS, SAMHSA, CSAT.. Behavior Modification and the Brain.. In 2000, the BBC published a news story on the brains of the famed London taxi drivers.. Taxi drivers in London must memorize an incredible amount of information in order to get their livery licenses.. Opiates/Opioids.. Opiates are drugs derived from opium.. At one time opioids referred to synthetic opiates only (drugs created to emulate opium, however different chemically).. Now the term Opioid is used for the entire family of opiates including natural, synthetic and semi-synthetic.. What it is Like to be Addicted.. Opiate addiction is a brain disease characterized by increased tolerance leading to more and more substance needed to achieve the same effect.. Also, there is continued use of substance despite negative consequences.. The Birth of a Stereotype.. For thousands of years opium was used as a medicine and relieved the suffering of many people for many aliments.. There were few cures so relieving suffering until the inevitable end was welcome treatment.. Treatment Law.. A significant breakthrough in the treatment of opioid addiction occurred with the introduction of methadone in the 1960s.. Modern Philosophy of Addicted Treatment.. Jose was running low on his substance of choice (S.. C.. ) one day; soon he would exhaust his supplies.. He began to plot and scheme as to how to obtain more.. Pharmacology of Buprenorphine.. Buprenorphine is a thebaine derivative that is legally classified as a narcotic.. It is available in numerous countries for use as an analgesic.. From preparation to staying drug free, the following is an in-depth look at what to expect from Buprenorphine Treatment..

    Original link path: /education/Introduction.cfm
    Open archive

  • Title: DATA-2000 law 30/100 patient limit on prescribing Suboxone (buprenorphine / naloxone) for the treatment of opioid addiction
    Descriptive info: 30 - 100 Patient Limit.. Limits on the number of patients.. buprenorphine.. -prescribing physicians can treat at any one time.. Brief Summary:.. In 2000 Congress passed.. DATA-2000.. , a law that allows physicians, to become eligible to prescribe specially approved opioid-based medications specifically for the treatment of opioid addiction.. (read full text of law below) Buprenorphine/naloxone.. (Suboxone ).. and buprenorphine.. (Subutex ).. became the first medications to be approved and affected by this law.. If physicians take and pass an 8 hour course and meet other qualifications, they become eligible to apply for a.. special waiver.. which allows them to treat addiction with above mentioned medications.. This same law, void of any supporting science, caps the number of addicted patients a physician can treat at any one time to 30 through the first year following certification, expandable to 100 patients thereafter.. No other medications have such restrictions, including the prescription drugs people get addicted to and die from.. Like many well-intentioned laws, the unintended consequences are significant.. Reasons to end these arbitrary government-mandated limits on life-saving care.. How prescribing physicians can increase their limit:.. Currently authorized physicians under DATA-2000 who have submitted their original intent at least one year ago can increase their government mandated patient cap to 100 patients.. Other DATA-2000 authorized physicians are limited to saving 30 patients at any one time.. SAMHSA.. has made it easy to expand the limit by automating the process.. Click here.. to go to the On-Line Notification Form to Increase Patient Limit Page.. Simply enter your DEA#, State, and State Lic# and submit right there.. If the site is down or you prefer to fill out the form by hand, you can download the new intent form.. and Fax it to 240-276-1630 or mail it to the address on the second page of the form, below the signature box.. SEC.. 1102.. CONTROLLED SUBSTANCES ACT AMENDMENTS.. Public Law 109-469 -12/29/2006.. Public Law 109-469 (Formerly Bill.. R.. 6344.. ).. Section 303(g)(2) of the Controlled Substances Act (21 U.. 823(g)(2)) is amended--.. (1) in subparagraph (B)(iii), by striking 'except that the' and inserting the following: 'unless,.. not sooner than 1 year after the date on which the practitioner submitted the initial notification, the practitioner submits a second notification to the Secretary of the need and intent of the practitioner to treat up to 100 patients.. A second notification under this clause shall contain the certifications required by clauses (i) and (ii) of this subparagraph.. The'; and.. (2) in subparagraph (J)--.. (A) in clause (i), by striking 'thereafter' and all that follows through the period and inserting 'thereafter.. ';.. (B) in clause (ii), by striking 'Drug Addiction Treatment Act of 2000' and inserting 'Office of National Drug Control Policy Reauthorization Act of 2006'; and.. (C) in clause (iii), by striking 'this paragraph should not remain in effect, this paragraph ceases to be in effect' and inserting 'subparagraph (B)(iii) should be applied by limiting the total number of patients a practitioner may treat to 30, then the provisions in such subparagraph (B)(iii) permitting more than 30 patients shall not apply, effective'.. An excerpt from DATA-2000 that shows how public law 109-469 amends it.. (this.. bill's.. law's changes in red).. Section 303(g)(2)(B)(iii).. (iii).. In any case in which the practitioner is not in a group practice, the total number.. *The total*.. of such patients of the practitioner at any one time will not exceed the applicable number.. For purposes of this clause, the applicable number is 30,.. except that the.. unless, not sooner than 1 year after the date on which the practitioner submitted the initial notification, the practitioner submits a second notification to the Secretary of the need and intent of the practitioner to treat up to 100 patients.. Secretary may by regulation change such total number.. (iv) In any case in which the practitioner is in a group practice, the total number of such patients of the group practice at any one time will not exceed the applicable number.. For purposes of this clause, the applicable number is 30, except that the Secretary may by regulation change such total number, and the Secretary for such purposes may by regulation establish different categories on the basis of the number of practitioners in a group practice and establish for the various categories different numerical limitations on the number of such patients that the group practice may have.. *.. [*Public law 109-56 made this change effective 8-2-2005].. Background.. Background:.. 8/2/2005 President Bush signed.. Bill S.. 45 into law.. , an amendment to the DATA2000 law, and now allows every qualified doctor within a group medical practice to prescribe Suboxone up to his or her individual physician limit of 30 patients.. You will find the entire.. lower on this page.. DATA2000 allowed physicians to prescribe medicines for opioid addiction in their private practices.. But it also restricted this health care to only 30 patients per practice.. The problem was that the law make no distinction between single practices and group practices.. The result was that large group practices such as Yale University/Hospital with over 600 doctors was limited to treating only 30 patients.. Total.. This law was changed 8/2/2005 so now every qualified doctor within a group medical practice to prescribe Suboxone up to his or her individual physician limit of 30 patients.. The House reviewed a bill (H.. 3634 11/03) to change this oversight and found the following:.. Actual findings from the Congress in November 2003:.. Neither Congress nor the DATA law intended that the quality of care would be less for patients receiving care in group practices, which are a principal mode of health care delivery in the United States.. The DATA law's 30-patient limit on group practices is having the unintended consequence of denying addiction treatment to patients who seek and require it, in direct contrast to the overall purpose of such law.. For practitioners in a group practice, the DATA law established a single 30-patient limit for the entire group practice, rather than a 30-patient limit per practitioner.. Qualified and trained practitioners practicing addiction treatment in group practice settings and academic health centers have realized an unexpected negative impact on their ability to serve their patients effectively and as anticipated by the DATA law, as a result of the law's patient limitation on group practices.. Read all findings at:.. congress.. org/congressorg/webreturn/?.. url=http://thomas.. loc.. gov/cgi-bin/query/z?c108:H.. 3634:.. See past Bills to Repeal the 30-Patient Ration.. Read about the history of Opioid laws.. Summary of DATA-2000.. Drug Addiction Treatment act of 2000(DATA 2000) summary.. Title XXXV, Section 3502 of the Children's Health Act of 2000 - Waiver Authority for Physicians Who Dispense or Prescribe Certain Narcotic Drugs for Maintenance Treatment or Detoxification Treatment.. DATA 2000 permits qualified physicians to obtain a waiver from the separate registration requirements of the Narcotic Addict Treatment Act to treat opioid addiction with Schedule III, IV, and V opioid medications or combinations of such medications that have been specifically approved by the Food and Drug Administration (FDA) for that indication.. Such medications may be prescribed and dispensed.. In order to qualify for a waiver under DATA 2000, physicians must hold a current State medical license, a valid DEA registration number, and must meet one or more of the following conditions:.. The physician holds a subspecialty board certification in addiction psychiatry from the American Board of Medical Specialties.. The physician holds an addiction certification from the American Society of Addiction Medicine.. The physician holds a subspecialty board certification in addiction medicine from the American Osteopathic Association.. The physician has completed not less than eight hours of training with respect to the treatment and management of opioid-addicted patients.. This training can be provided through classroom situations, seminars at professional society meetings, electronic communications, or otherwise.. The training must be sponsored by one of five organizations authorized in the DATA 2000 legislation to sponsor such training, or by any other organization that the Secretary of the Department of Health and Human Services (the Secretary) determines to be appropriate.. The physician has participated as an investigator in one or more clinical trials leading to the approval of a narcotic drug in Schedule III, IV, or V for maintenance or detoxification treatment, as demonstrated by a statement submitted to the Secretary by the sponsor of such approved drug.. The physician has other training or experience, considered by the State medical licensing board (of the State in which the physician will provide maintenance or detoxification treatment) to demonstrate the ability of the physician to treat and manage opioid-addicted patients.. The physician has other training or experience the Secretary considers demonstrates the ability of the physician to treat and manage opioid-addicted patients.. In addition, physicians must attest that they have the capacity to refer addiction treatment patients for appropriate counseling and other non-pharmacologic therapies, and that they will not have more than 30 patients on such addiction treatment at any one time.. Unless they qualify to treat up to 100 patients.. (Note: The patient limit applies to both physicians in solo practice and to entire group practices, and is not affected by the number of physician or group practice locations.. ).. * amended.. For the.. 3-year period.. after the passage of DATA 2000, States may not preclude practitioners from dispensing or prescribing eligible medications for opioid maintenance or detoxification treatment.. The effect of the three-year provision in DATA 2000 is to put into abeyance current State law or regulations prohibiting physicians from prescribing Subutex or Suboxone for the treatment of opioid addiction, and to prevent State regulatory agencies from prohibiting prescribing by regulation.. The FDA approved Subutex and Suboxone on October 8, 2002.. A 2002 appropriations bill amended the DATA 2000 three-year State preemption provision to start on the date that the FDA approved Subutex and Suboxone.. Thus, until October 8, 2005 States may not preclude practitioners from dispensing or prescribing eligible medications for opioid maintenance or detoxification treatment unless the State passes legislation to that effect.. The Secretary and the Attorney General are authorized to evaluate the effectiveness and impact of the program and to discontinue it with 60 days notice.. Read results of three year evaluation (5-5-2006) PDF.. Entire DATA-2000 Text (Updated 12-29-2006).. [[Page 114 STAT.. 1101]].. Public Law 106-310.. 106th Congress.. An Act.. TITLE NOTE: Drug Addiction Treatment Act of 2000.. XXXV--WAIVER AUTHORITY FOR PHYSICIANS WHO DISPENSE OR PRESCRIBE CERTAIN NARCOTIC DRUGS FOR MAINTENANCE TREATMENT OR DETOXIFICATION TREATMENT.. 3501.. NOTE: 21 USC 801 note.. SHORT TITLE.. This title may be cited as the Drug Addiction Treatment Act of 2000''.. 3502.. AMENDMENT TO CONTROLLED SUBSTANCES ACT.. (a) In General.. --Section.. 303(g).. of the Controlled Substances Act (21 U.. 823(g)) is amended--.. 1223]].. (1) in paragraph (2), by striking (A) security'' and inserting (i) security'', and by striking (B) the maintenance'' and inserting (ii) the maintenance'';(2) by redesignating paragraphs (1) through (3) as subparagraphs (A) through (C), respectively;(3) by inserting (1)'' after (g)'';(4) by striking Practitioners who dispense'' and inserting Except as provided in paragraph (2), practitioners who dispense''; and (5) by adding at  ...   manner in which medical services are provided.. (ii) NOTE: Deadline.. Not later than 120 days after the date of the enactment of the Drug Addiction Treatment Act of 2000, the Secretary shall issue a treatment improvement protocol containing best practice guidelines for the treatment and maintenance of opiate-dependent patients.. The Secretary shall develop the protocol in consultation with the Director of the National Institute on Drug Abuse, the Administrator of the Drug Enforcement Administration, the Commissioner of Food and Drugs, the Administrator of the Substance Abuse and Mental Health Services Administration and other substance abuse disorder professionals.. The protocol shall be guided by science.. (I) During the 3-year period beginning on the date of the enactment of the Drug Addiction Treatment Act of 2000, a State may not preclude a practitioner from dispensing or prescribing drugs in schedule III, IV, or V, or combinations of such drugs, to patients for maintenance or detoxification treatment in accordance with this paragraph unless, before the expiration of that 3-year period, the State enacts a law prohibiting a practitioner from dispensing such drugs or combinations of drug.. (J)(i) NOTE: Effective date.. This paragraph takes effect on the date of the enactment of the Drug Addiction Treatment Act of 2000, and remains in effect.. thereafter.. except as provided in clause (iii) (relating to a decision by the Secretary or the Attorney General that this paragraph should not remain in effect).. **.. (ii) For purposes relating to clause (iii), the Secretary and the Attorney General may, during the 3-year period beginning on the date of the enactment of the.. Drug Addiction Treatment Act of 2000.. Office of National Drug Control Policy Reauthorization Act of 2006'**.. , make determinations in accordance with the following: (I) The Secretary may make a determination of whether treatments provided under waivers under subparagraph (A).. 1227]].. have been effective forms of maintenance treatment and detoxification treatment in clinical settings; may make a determination of whether such waivers have significantly increased (relative to the beginning of such period) the availability of maintenance treatment and detoxification treatment; and may make a determination of whether such waivers have adverse consequences for the public health.. (II) The Attorney General may make a determination of the extent to which there have been violations of the numerical limitations established under subparagraph (B) for the number of individuals to whom a practitioner may provide treatment; may make a determination of whether waivers under subparagraph (A) have increased (relative to the beginning of such period) the extent to which narcotic drugs in schedule III, IV, or V or combinations of such drugs are being dispensed or possessed in violation of this Act; and may make a determination of whether such waivers have adverse consequences for the public health.. (iii) NOTE: Federal Register, publication.. Effective date.. If, before the expiration of the period specified in clause (ii), the Secretary or the Attorney General publishes in the Federal Register a decision, made on the basis of determinations under such clause,.. that this paragraph should not remain in effect, this paragraph ceases to be in effect.. subparagraph (B)(iii) should be applied by limiting the total number of patients a practitioner may treat to 30, then the provisions in such subparagraph (B)(iii) permitting more than 30 patients shall not apply, effective.. 60 days after the date on which the decision is so published.. The Secretary shall in making any such decision consult with the Attorney General, and shall in publishing the decision in the Federal Register include any comments received from the Attorney General for inclusion in the publication.. The Attorney General shall in making any such decision consult with the Secretary, and shall in publishing the decision in the Federal Register include any comments received from the Secretary for inclusion in the publication.. ''.. (b) Conforming Amendments.. --Section 304 of the Controlled Substances Act (21 U.. 824) is amended--(1) in subsection (a), in the matter after and below paragraph (5), by striking section 303(g)'' each place such term appears and inserting section 303(g)(1)''; and(2) in subsection (d), by striking section 303(g)'' and inserting section 303(g)(1)''.. (c) Additional Authorization of Appropriations.. --For the purpose of assisting the Secretary of Health and Human Services with the additional duties established for the Secretary pursuant to the amendments made by this section, there are authorized to be appropriated, in addition to other authorizations of appropriations that are available for such purpose, such sums as may be necessary for each of fiscal years 2001 through 2003.. END-DATA-2000.. Amendment that allows physicians in group practices to prescribe to 30 patients individually regardless of whether they are in a group or sole practice.. It went into effect 8/2/2005.. Amendment:.. One Hundred Ninth Congress.. of the.. United States of America.. AT THE FIRST SESSION.. Begun and held at the City of Washington on Tuesday,.. the fourth day of January, two thousand and five.. An Act.. To amend the Controlled Substances Act to lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices, and for other purposes.. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,.. SECTION 1.. MAINTENANCE OR DETOXIFICATION TREATMENT WITH CERTAIN NARCOTIC DRUGS; ELIMINATION OF 30-PATIENT LIMIT FOR GROUP PRACTICES.. (a) IN GENERAL- Section 303(g)(2)(B) of the Controlled Substances Act (21 U.. 823(g)(2)(B)) is amended by striking clause (iv).. (b) CONFORMING AMENDMENT- Section 303(g)(2)(B) of the Controlled Substances Act (21 U.. 823(g)(2)(B)) is amended in clause (iii) by striking 'In any case' and all that follows through 'the total' and inserting 'The total'.. (c) EFFECTIVE DATE- This section shall take effect on the date of enactment of this Act.. Speaker of the House of Representatives.. Vice President of the United States and.. President of the Senate.. END.. Read the entire Amendment with all recorded discussion, co-sponsors and supporters.. -PDF.. This rule amends the Federal opioid treatment program regulations by adding buprenorphine to the list of approved opioid treatment medications that may be used in federally certified opioid treatment programs.. August 3rd, 2006.. Contact: Peter Carr (202) 224-9854,.. Jared Whitley (202) 224-0134.. HATCH, LEVIN TOUT SUCCESS OF DRUG ADDICTION TREATMENT ACT.. Washington - Sen.. Orrin G.. Hatch (R-Utah) joined Sen.. Carl Levin (D-Mich.. ) today at a symposium discussing the success of their Drug Addiction Treatment Act of 2000, which among other things expanded the ability of doctors to prescribe buprenorphine to recovering heroin addicts.. Hatch's prepared remarks follow:.. The topic of drug abuse is so important to me that I will always make time to talk to on the subject.. First off, let me commend my colleague, Senator Carl Levin of Michigan for his leadership.. Carl is one of the real experts in the Senate on drug abuse, and I appreciate all he s done for our country on this issue.. In helping bring about new methods and medications to treat heroin addiction, Carl and I have worked side by side for many years.. We ve worked together on a bipartisan basis on drug issues with Senator Joe Biden and our great former colleague Senator Pat Moynihan and many others, including many of you here today.. I want to recognize Director Nora Volkow of the National Institute of Drug Abuse and Director Westley Clark of the Center for Substance Abuse and Treatment.. These two have some of the most challenging jobs in the government, and we thank them for their good work.. Dr.. Charles Schuster and I are long time friends.. We worked with Nancy Reagan many years ago on the Just Say No campaign.. Herbert Kleber was drug czar under first President Bush.. Let me also recognize doctors David Feillin and Jim Finch, who are leaders in their fields.. All of you have joined Carl and me today because we know that this country can develop better treatments for drug abuse.. Nobody in this audience needs to be reminded of what is at stake, but it is worth emphasizing again.. We need to break the pernicious cycle between heroin addiction and crime.. If we can encourage thousands of addicts into rehabilitation today, they and their families will be able to live more productive lives tomorrow.. We can make major gains in our nation s crime problem and improve the social structure and stability of many families who today live under the scourge of drug abuse.. I am proud of the legislation we passed in 2000.. The Drug Addiction Treatment Act was a groundbreaking law that allows certified physicians to prescribe appropriate medications in their offices, like the drug buprenorphine, to help people trying to break the shackles of heroin addiction.. Prior to passage of this law, medical treatment for that kind of addiction and dependence was restricted to designated drug abuse treatment centers.. This kind of movement is like building a wall brick by brick.. It takes a lot of time and work and a solid foundation and that s what we re constructing today.. We must allow qualified doctors to treat more addicts than can be treated under current law.. Currently, doctors are allowed only 30 such patients at a time.. But why should we bind a healer s hands from helping as many as he or she could?.. Let me share with you a letter from Dr.. Glen Hanson, former director of NIDA and a professor of toxicology and pharmacology at the University of Utah.. Hanson told me that In Utah the use of buprenorphine to manage opiate dependency is enthusiastically recommended by clinicians who are certified and actively working with opiate-dependent patients.. Hanson shared some success stories with me.. One is Dr.. Michael Measom, a physician at Utah Valley Mental Health, who says, I love to prescribe buprenorphine because it has been such a useful and successful drug for so many patients.. It has increased my ability to serve patients, especially in an ambulatory detoxification setting.. Measom says that many of his patients were able to turn their lives around by using buprenorphine and participating in treatment.. He shared with me examples of how buprenorphine treatment helped: (1) a mother reconnect with her son; (2) save several marriages; and (3) several patients return to the workforce and become productive citizens.. Measom pointed out that one of the many benefits of buprenorphine is that patients are able to fully benefit from individual and group therapy sessions because they are able to concentrate better and be more active in their treatment.. Senators Biden, Levin, and I are hoping to expand the number of patients qualified doctors are allowed to treat and we need all of you to let your senators know that you support this effort.. And although I hate to leave you with a threat, in this case, I will do so.. If you do not work our proposed change in the law, Sen.. Levin and I are going to sic Jackie Parker on you.. And I ve always found it is easier to do just what Jackie wants than to argue with her.. ###..

    Original link path: /30_patient_limit.cfm
    Open archive

  • Archived pages: 170